Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Nitazoxanide / Ofloxacin Tablets bulk supplier for pharma manufacturers

Nitazoxanide / Ofloxacin Tablets 500mg + 200 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 500mg + 200 mg

Reference Brands: Generic formulations marketed under different names

Category: Antibiotics

The salt combination Nitazoxanide and Ofloxacin is used for the treatment of Gastrointestinal Infection, Urinary Tract Infections, Respiratory Infections, Skin Infections, Soft Tissue Infections, Sexually Transmitted Infections and other conditions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Nitazoxanide and Ofloxacin is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · Gastrointestinal Infection · Urinary Tract Infections · Respiratory Infections · Skin Infections · Soft Tissue Infections · Sexually Transmitted Infections · Eye And Ear Infection

Nitazoxanide 500 mg and Ofloxacin 200 mg combination tablet is a prescription medication designed to treat mixed gastrointestinal infections, including diarrhea and dysentery caused by both bacteria and protozoal pathogens. This dual-action formulation combines nitazoxanide, an antiparasitic agent that interferes with the energy metabolism of protozoa and certain helminths, and ofloxacin, a broad-spectrum fluoroquinolone antibiotic that inhibits bacterial DNA replication, effectively eliminating pathogenic bacteria.

The combination provides targeted therapy against both bacterial and protozoal causes of gastrointestinal infections, offering rapid relief from symptoms such as abdominal pain, cramps, dehydration, and abnormal stool consistency. It is typically administered orally over a short course, often three days, to ensure effective eradication of the infection while promoting patient compliance.

Nitazoxanide and Ofloxacin tablets are widely used in regions where mixed infections are common, providing a convenient and efficient approach to managing gastrointestinal disorders. Proper medical supervision is essential to ensure safe and effective use, minimize potential side effects, and prevent the development of antimicrobial resistance. This combination offers a reliable treatment option for restoring intestinal health and improving overall recovery in patients with mixed gastrointestinal infections.

Nitazoxanide / Ofloxacin Tablets — third party manufacturing & bulk supply

Nitazoxanide / Ofloxacin Tablets 500mg + 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Nitazoxanide / Ofloxacin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Nitazoxanide / Ofloxacin Tablets →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Nitazoxanide / Ofloxacin Tablets are used to treat mixed gastrointestinal infections caused by bacteria and protozoa, including diarrhea, dysentery, giardiasis, and bacterial gastroenteritis. They help relieve symptoms such as abdominal cramps, diarrhea, and dehydration by targeting both bacterial and protozoal pathogens.

These tablets are made from nitazoxanide, an antiparasitic agent that inhibits the energy metabolism of protozoa, and ofloxacin, a fluoroquinolone antibiotic that prevents bacterial DNA replication, providing dual-action against mixed gastrointestinal infections.

Trade names include Nitroflox, Nitozoflox, and other regional generics.

Nitazoxanide / Ofloxacin Tablets are manufactured by several pharmaceutical companies, particularly in India and LATAM countries, where mixed gastrointestinal infections are common.

The generic name is nitazoxanide + ofloxacin.

Brand names include Nitroflox, Nitozoflox, and other generics.

It is manufactured in countries such as India, LATAM, and other regions with pharmaceutical facilities producing combination therapy for gastrointestinal infections.

Related Products

Rifaximin

Strength:
100 mg/5 mL, 200 mg, 550 mg

Form: Tablet / Oral Suspension

Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)

View Details
Ceftaroline

Strength:
600 mg

Form: Injection

Reference Brands: Teflaro (USA), Zinforo (EU)

View Details
Secnidazole

Strength:
2 g

Form: Oral granules/ tablets

Reference Brands: Solosec (USA)

View Details
Omaveloxolone

Strength:
150 mg

Form: Tablets

Reference Brands: Skyclarys (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.